{
    "clinical_study": {
        "@rank": "23559", 
        "arm_group": {
            "arm_group_label": "hepatocellular carcinoma"
        }, 
        "brief_summary": {
            "textblock": "According to the BCLC guidelines, surgical resection of hepatocellular carcinoma\n      complicating cirrhosis is restricted to patients with preserved liver function.\n\n      However, the surgical indications for hepatocellular carcinoma  with portal hypertension\n      remain controversial."
        }, 
        "brief_title": "Assessment of Portal Hypertension Before Liver Resection in Patients With Hepatocellular Carcinoma", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Primary Liver Cancers", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Hypertension", 
                "Hypertension, Portal", 
                "Liver Neoplasms", 
                "Carcinoma, Hepatocellular"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients with hepatocellular carcinoma who undergo surgical resection (intention to\n             treat analysis)\n\n        Exclusion Criteria:\n\n          -  extra-hepatic disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "All patients with hepatocellular carcinoma"
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 20, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02145013", 
            "org_study_id": "LIM Chetana"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "portal hypertension, cirrhosis, hepatocellular carcinoma, surgical treatment", 
        "lastchanged_date": "May 21, 2014", 
        "location": {
            "contact": {
                "email": "chetana.lim@gmail.com", 
                "last_name": "Chetana Lim"
            }, 
            "facility": {
                "address": {
                    "city": "Creteil", 
                    "country": "France", 
                    "zip": "94000"
                }, 
                "name": "Henri Mondor University Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "1", 
        "official_title": "Assessment of Portal Hypertension Before Liver Resection in Patients With Hepatocellular Carcinoma", 
        "overall_contact": {
            "email": "daniel.azoulay@hmn.aphp.fr", 
            "last_name": "Daniel Azoulay, MD, PhD"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: haute autorit\u00e9 de sante", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "In-hospital or 90-day mortality", 
            "measure": "Mortality", 
            "safety_issue": "Yes", 
            "time_frame": "90 day"
        }, 
        "reference": {
            "PMID": "18549877", 
            "citation": "Ishizawa T, Hasegawa K, Aoki T, Takahashi M, Inoue Y, Sano K, Imamura H, Sugawara Y, Kokudo N, Makuuchi M. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology. 2008 Jun;134(7):1908-16. doi: 10.1053/j.gastro.2008.02.091. Epub 2008 Mar 8. PubMed"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02145013"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Henri Mondor University Hospital", 
            "investigator_full_name": "Chetana LIM", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "overall and liver-related complications including liver failure, ascites, biliary fistula, bleeding, pulmonary complications, and renal complications.\nGrading system according to Clavien-Dindo classification", 
            "measure": "morbidity", 
            "safety_issue": "Yes", 
            "time_frame": "90 day"
        }, 
        "source": "Henri Mondor University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Henri Mondor University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}